Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Amir

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Nature Genetics|October 3, 1999
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2R E Amir, I B Van den Veyver, M Wan, et al.
Cancer Treatment Reviews|February 2, 2016
Evolution in the eligibility criteria of randomized controlled trials for systemic cancer therapiesA Srikanthan, F Vera-Badillo, J Ethier, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 7, 2015
Impact of Geographic Region on Benefit of Approved Anticancer Drugs Evaluated in International Phase III Clinical TrialsH Y AlHashem, M Al-Mubarak, F E Vera-Badillo, et al.
Cancer Investigation|February 20, 2014
Association of aromatase inhibitors with coronary heart disease in women with early breast cancerB Seruga, V Zadnik, C Grasic Kuhar, et al.
The Journal of Sports Medicine and Physical Fitness|February 4, 2009
Acute incremental exercise to maximal performance does not cause alterations in serum oxidant levels of healthy young individualsO Amir, C Yamin, M Sagiv, et al.
Journal of Medical Genetics|June 3, 2004
A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPROD G R Evans, D M Eccles, N Rahman, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 1, 2008
Discordance between receptor status in primary and metastatic breast cancer: an exploratory study of bone and bone marrow biopsiesE Amir, W S Ooi, C Simmons, et al.
European Journal of Applied Physiology|September 2, 2008
IL6 (-174) and TNFA (-308) promoter polymorphisms are associated with systemic creatine kinase response to eccentric exerciseChen Yamin, José Alberto Ramos Duarte, José Manuel Fernandes Oliveira, et al.
Clinical & Experimental Metastasis|August 22, 2009
Mechanisms and pathways of bone metastasis: challenges and pitfalls of performing molecular research on patient samplesT R Cawthorn, E Amir, R Broom, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2011
An economic analysis of the INTEREST trial, a randomized trial of docetaxel versus gefitinib as second-/third-line therapy in advanced non-small-cell lung cancerA M Horgan, P A Bradbury, E Amir, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Nature Genetics|October 3, 1999
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2R E Amir, I B Van den Veyver, M Wan, et al.
Cancer Treatment Reviews|February 2, 2016
Evolution in the eligibility criteria of randomized controlled trials for systemic cancer therapiesA Srikanthan, F Vera-Badillo, J Ethier, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 7, 2015
Impact of Geographic Region on Benefit of Approved Anticancer Drugs Evaluated in International Phase III Clinical TrialsH Y AlHashem, M Al-Mubarak, F E Vera-Badillo, et al.
Cancer Investigation|February 20, 2014
Association of aromatase inhibitors with coronary heart disease in women with early breast cancerB Seruga, V Zadnik, C Grasic Kuhar, et al.
The Journal of Sports Medicine and Physical Fitness|February 4, 2009
Acute incremental exercise to maximal performance does not cause alterations in serum oxidant levels of healthy young individualsO Amir, C Yamin, M Sagiv, et al.
Journal of Medical Genetics|June 3, 2004
A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPROD G R Evans, D M Eccles, N Rahman, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 1, 2008
Discordance between receptor status in primary and metastatic breast cancer: an exploratory study of bone and bone marrow biopsiesE Amir, W S Ooi, C Simmons, et al.
European Journal of Applied Physiology|September 2, 2008
IL6 (-174) and TNFA (-308) promoter polymorphisms are associated with systemic creatine kinase response to eccentric exerciseChen Yamin, José Alberto Ramos Duarte, José Manuel Fernandes Oliveira, et al.
Clinical & Experimental Metastasis|August 22, 2009
Mechanisms and pathways of bone metastasis: challenges and pitfalls of performing molecular research on patient samplesT R Cawthorn, E Amir, R Broom, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2011
An economic analysis of the INTEREST trial, a randomized trial of docetaxel versus gefitinib as second-/third-line therapy in advanced non-small-cell lung cancerA M Horgan, P A Bradbury, E Amir, et al.
Pageof 9